Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,106 | 58,761 | 71,679 | 85,963 | 229,592 |
| Marketable Securities | 92,731 | 111,410 | 119,542 | 77,030 | 181,747 |
| Receivables | 113,534 | 98,229 | 110,205 | 67,414 | 82,043 |
| Inventories | 102,698 | 91,834 | 92,489 | 72,397 | 56,505 |
| Other current assets | 0 | 0 | 0 | 2,350 | 2,539 |
| TOTAL | $396,813 | $365,115 | $395,619 | $307,319 | $554,640 |
| Non-Current Assets | |||||
| PPE Net | 20,022 | 17,859 | 22,633 | 29,936 | 26,162 |
| Investments And Advances | 103,426 | 120,023 | 158,016 | 178,952 | 174,841 |
| Intangibles | 370,089 | 369,804 | 421,054 | 425,702 | 234,272 |
| Other Non-Current Assets | 73,447 | 72,692 | 57,514 | 49,982 | 49,761 |
| TOTAL | $566,984 | $580,378 | $659,217 | $684,572 | $485,036 |
| Total Assets | $963,797 | $945,493 | $1,054,836 | $991,891 | $1,039,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,486 | 17,850 | 17,674 | 26,662 | 51,770 |
| Accounts payable and accrued liabilities | 78,345 | 85,366 | 106,061 | 65,309 | 44,512 |
| Other current liabilities | 1,876 | 1,046 | 5,793 | 1,989 | 1,291 |
| TOTAL | $111,248 | $114,029 | $141,321 | $105,302 | $114,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,899 | 44,016 | 52,398 | 9,265 | N/A |
| Other Non-Current Liabilities | 24,271 | 32,263 | 25,845 | 19,516 | 15,216 |
| TOTAL | $57,444 | $84,593 | $87,658 | $44,571 | $39,375 |
| Total Liabilities | $168,692 | $198,622 | $228,979 | $149,873 | $153,435 |
| Shareholders' Equity | |||||
| Common Shares | 534,266 | 540,046 | 599,055 | 628,854 | 694,351 |
| Retained earnings | 154,794 | 150,888 | 161,755 | 191,647 | 174,545 |
| Other shareholders' equity | 80,337 | 29,946 | 41,383 | -259 | -1,386 |
| TOTAL | $795,105 | $746,871 | $825,857 | $842,018 | $886,241 |
| Total Liabilities And Equity | $963,797 | $945,493 | $1,054,836 | $991,891 | $1,039,676 |